Why Clovis Oncology Faces Some Difficulty With Its Midstage Cancer Study

Immunomedics shares dropped sharply on Monday after the firm presented interim data from its midstage bladder cancer study at the European Society for Medical Oncology (ESMO) Annual Congress in........»»

Shares of Clovis Oncolog.....»»

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak.....»»

Shares of Clovis Oncology Inc. .....»»

Spectrum Pharma shares were halved on Thursday after the firm provided an update on its midstage cancer study some updates on its late-stage programs with the FDA......»»

Kura Oncology Should Be On Your Radar With Upcoming Presentation For Cancer Study.....»»

Shares of the large-cap biopharma Seattle Genetics, Inc. (NASDAQ: SGEN) were advancing strongly Monday following a clinical trial readout from the company. read more.....»»

ImmunoGen shares dropped on Monday after the firm released data from its late-stage ovarian cancer study at the European Society for Medical Oncology (ESMO) 2019 Congress in Barcelona, Spain......»»

Eli Lilly shares dipped on Monday after the firm announced results from its midstage clinical trial for the treatment of lung cancer......»»

Uncertainty over Bristol-Myers Squibb Co (NYSE: BMY)'s impending deal to acquire Celgene Corporation (NASDAQ: CELG) and an adverse clinical trial readout were dragging the shares of the large-cap pharma company lo read more.....»»

Turning Point Therapeutics shares dipped on Friday after the firm posted interim data for its midstage study in ROS1-positive non-small cell lung cancer patients......»»

Clovis Oncology may have thought that it could sneak an announcement by late on Friday, but its shares were definitely paying the price Monday morning......»»

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Clovis Oncology Inc. stock tumbled more than 14% in after-hours trading Friday after the compa.....»»

UAB Medicine is leading an initiative to study brain tumors in dogs, which may lead to further investigations to treat humans. The five-year, $2.6 million project project is funded by the Comparative Oncology Program of the National Cancer Instit.....»»

Celldex Therapeutics shares were absolutely crushed on Monday morning after the firm announced results to its midstage breast cancer study......»»

Spectrum Pharmaceuticals saw its shares make a handy gain early on Tuesday after the firm provided an update on its midstage non-small cell lung cancer study......»»

Clovis Oncology won the fast-tracked verdict it hoped for on Friday when the U.S. Food and Drug Administration approved marketing the company's ovarian cancer drug rucaparib to treat a broader range of patients. The FDA approved the Boulder-based .....»»

Clovis Oncology's (CLVS) PARP inhibitor, Rubraca, gets its first approval in Europe for the treat.....»»

Merrimack Pharmaceuticals shares were absolutely getting crushed on Monday after the firm gave an update from its midstage pancreatic cancer study......»»